HEMO-GE.ApS: Financial statements 2024
CVR: 39076322
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
HEMO-GE.ApS (CVR 39076322) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -5,711 and a net result of DKK 96,416 compared with DKK 2,514,622 the year before. Equity in the 2024 report amounted to DKK 4,370,308. The solvency ratio was 99.3%.
- Gross Profit
- DKK -5,711
- Profit/Loss
- DKK 96,416
- Equity
- DKK 4,370,308
- Total Assets
- DKK 4,402,525
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -6 t. | 96 t. | 4.4 mio. | 0 |
| 2023 | - | -5 t. | 2.5 mio. | 4.4 mio. | - |
| 2022 | - | -6 t. | 124 t. | 2 mio. | - |
| 2021 | - | -4 t. | 96 t. | 2 mio. | - |
| 2020 | - | -4 t. | 96 t. | 2.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
HEMO-GE.ApS has published its annual report for 2023. Gross profit came to DKK -5,150, and the net result was DKK 2,514,622.
As of May 2, 2024, LLM STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of HEMO-GE.ApS.
About HEMO-GE.ApS
HEMO-GE.ApS is a Danish company of the type Anpartsselskab based in Rudkøbing, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Graakjær Eriksen. The company is owned by Henrik Graakjær Eriksen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,000 and a net result of DKK 90,958 compared with DKK 96,416 the year before. Equity in the 2025 report amounted to DKK 4,326,266.